Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
What is your approach to managing a kidney transplant patient who develops BK viremia after treatment for rejection?
Related Questions
Would you recommend starting an SGLT2i in a patient with a kidney transplant and moderately increased albuminuria?
Do you routinely use markers or tests other than serum creatinine when estimating GFR to determine if patients with liver failure, not on dialysis, meet criteria for a simultaneous liver-kidney transplant?
Should all kidney transplant patients be started on statin therapy post operatively given their increased risk of CVD?
What is the role of APOL1 genotyping in the evaluation of a living kidney donor?
How do you counsel patients who experience diarrhea from mycophenolate mofetil (Cellcept)?
Would you order a repeat DEXA scan 1 year later for a kidney transplant patient who had an initial DEXA scan within the first 6 months post-transplant showing osteopenia but no history of fractures, and who has been stable on glucocorticoid-free immunosuppressive therapy?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
How would you approach management of a patient with ESRD on the transplant list who is found to have high titer APS labs (ACL, B2GP1, LAC)?
Is there a BMI cutoff for which you no longer recommend kidney transplantation in a patient with end stage kidney disease and obesity?
How do you approach the management of a kidney transplant recipient who develops de novo donor-specific antibodies but shows no clinical signs of rejection or graft dysfunction?
